Robert A. Ziroyan

Atrinsic, Inc. is a direct marketing company. It offers two services: subscription services and transactional services. The subscription services contents applications direct to users working with wireless carriers and other distributors. The transactional services offers full service online marketing and distribution services which are targeted and measurable online campaigns and programs for marketing partners, corporate advertisers, or their agencies, generates qualified customer leads, online responses and activities and increases brand recognition. The company was founded on February 3, 1994 and is headquartered in Boston, MA.

Protagenic Therapeutics, Inc. discovers and develops neuropeptides for the treatment of anxiety and depression based mood disorders. It focuses on the discovery and development of naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. The firm products include PT00114 and PT00121, which are peptide-based formulations for the treatment of anxiety and depression disorders. The company is headquartered in New York, NY.